Johnson & Johnson
$162.709876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$162.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.40 (-0.25%) Today
+$0.32 (+0.20%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell JNJ and other stocks, options, and ETFs commission-free!
About JNJ
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. The listed name for JNJ is Johnson & Johnson.
CEO
Alex Gorsky
Employees
132,200
Headquarters
New Brunswick, New Jersey
Founded
1887
Market Cap
427.47B
Price-Earnings Ratio
25.19
Dividend Yield
2.48
Average Volume
9.29M
High Today
$164.14
Low Today
$161.81
Open Price
$163.17
Volume
6.84M
52 Week High
$164.14
52 Week Low
$109.16
Collections
JNJ News
ReutersJan 18
South Africa to get 9 million J&J vaccine shots - ministry
JOHANNESBURG (Reuters) - South Africa, which has yet to receive its first coronavirus vaccine doses, will be getting 9 million from Johnson & Johnson, the healt
Analyst Ratings
67%
of 18 ratings
Buy
67%
Hold
33%
Sell
0%
JNJ Earnings
$0.00
$0.86
$1.72
$2.58
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Jan 26, Pre-Market
